Influenza News and Research

Latest Influenza News and Research

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

A team of researchers has explored the possibility of coating surfaces with TiO2 as a tool to inactivate SARS-CoV-2.

7 Oct 2021

Critical function of IL-7 in diagnosis, prognosis, and treatment of COVID-19 patients

In this review, researchers summarized the therapeutic and pathogenic role of IL-7 in patients with COVID-19 and examined the promising role of IL-7 as a vaccine adjuvant.

7 Oct 2021

Enisamium shows potential as antiviral therapy for COVID-19

Researchers studied the effect of enisamium on the growth and proliferation of Caco-2 and normal human bronchial epithelial cells.

6 Oct 2021

Transmission of SARS-CoV-2 during a 2-hour domestic flight

A new study investigated a cluster of COVID-19 infections among travelers who were likely exposed to an index patient in an airplane.

6 Oct 2021

A possible protective genetic polymorphism in COVID-19

A new study discusses the role of a mucin gene enhancer on the clinical phenotype of the COVID-19.

5 Oct 2021

New low-cost ventilator could address the shortage of ventilators in developing countries

A new low-cost ventilator design invented during COVID-19 could address the global shortage of ventilators for other respiratory diseases.

5 Oct 2021

Anti-CD20 therapy patients can develop immune responses after SARS-CoV-2 vaccination

A new systematic review and meta-analysis focused on the humoral and cell-mediated immune responses after COVID-19 vaccination in patients undergoing anti-CD20 antibodies treatment.

5 Oct 2021

Depressed seroconversion in immunocompromised COVID-19 vaccine recipients

Researchers from the University of Singapore have reviewed the data in post-vaccinated immunocompromised patients to examine the effectiveness of these vaccines in these patients.

5 Oct 2021

UD chemical engineer aims to improve the delivery of therapeutic medicines to the body

The human body has built-in protections to keep pathogens out. That sneezing fit or stuffy nose when you have a cold? That's your body leveraging mucosal linings in your respiratory system to expel the offending virus.

5 Oct 2021

SARS-CoV-2 mRNA vaccines elicit higher levels of antibodies compared to natural infection

Researchers from the US recently characterized the scale and specificity of SARS-CoV-2 spike-reactive antibodies from 23 participants who received SARS-CoV-2 mRNA vaccines and 10 acutely infected health care workers. They found that primary mRNA vaccination and infection elicited S1- and S2-reactive antibodies, while secondary mRNA vaccination elicited mostly S1 antibodies.

4 Oct 2021

mRNA vaccination induces strong humoral immune responses against SARS-CoV-2 in over 80's

A recent study assesses the serological and cellular responses to Pfizer’s BNT162b2 mRNA vaccine in people aged 80-96 years.

4 Oct 2021

Health-related quality of life of COVID-19 patients with long-COVID: Study

Researchers conducted a survey-based study and assessed the impact of long COVID on the health-related quality of life in Japanese COVID-19 patients.

4 Oct 2021

Mandatory vaccines for health care workers might upend nurses’ training

Kaitlyn Hevner expects to complete a 15-month accelerated nursing program at the University of North Florida in Jacksonville in December. For her clinical training this fall, she's working 12-hour shifts on weekends with medical-surgical patients at a hospital.

4 Oct 2021

COVID-19 may trigger hyperglycemia by disrupting key metabolic signals to cause severe disease

COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

2 Oct 2021

CDC awards $15.88 million to Wayne State University to study viral infection surveillance

The U.S. Centers for Disease Control and Prevention has awarded $15.88 million to the Wayne State University School of Medicine's Department of Emergency Medicine to be the epicenter of a national study on viral infections that present in emergency departments across the county.

1 Oct 2021

EKF Diagnostics appoints Luke Daum as Chief Scientific Officer

EKF Diagnostics, the global in vitro diagnostics company, has appointed Luke Daum PhD as Chief Scientific Officer, bringing a wealth of expertise in molecular-based diagnostics to EKF’s leadership team.

From EKF Diagnostics 1 Oct 2021

Early-stage interaction of monocytes with SARS-CoV-2-infected epithelial cell decides COVID-19 severity

A team of scientists from the USA and France has recently unveiled the mechanism of immune dysregulation in coronavirus disease 2019 (COVID-19) patients by analyzing the early-stage interaction between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected epithelial cells and immune cells. The study is currently available on the bioRxiv* preprint server.

30 Sep 2021

Study investigates long-COVID symptoms in people recovering from COVID-19 infection

This new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.

30 Sep 2021

The applications of nanomaterials against viral disease

The application of nanomaterials in the diagnosis, prevention, and treatment of viral diseases is reviewed in detail, highlighting areas of significant progress or stagnation from the past few decades.

30 Sep 2021

Immunocompromised patients show decreased response to SARS-CoV-2 mRNA vaccines

Researchers explore the germinal cell responses in both healthy individuals and kidney transplant patients in their recent study.

29 Sep 2021

Influenza News and Research

Latest Influenza News and Research

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

Critical function of IL-7 in diagnosis, prognosis, and treatment of COVID-19 patients

Enisamium shows potential as antiviral therapy for COVID-19

Transmission of SARS-CoV-2 during a 2-hour domestic flight

A possible protective genetic polymorphism in COVID-19

New low-cost ventilator could address the shortage of ventilators in developing countries

Anti-CD20 therapy patients can develop immune responses after SARS-CoV-2 vaccination

Depressed seroconversion in immunocompromised COVID-19 vaccine recipients

UD chemical engineer aims to improve the delivery of therapeutic medicines to the body

SARS-CoV-2 mRNA vaccines elicit higher levels of antibodies compared to natural infection

mRNA vaccination induces strong humoral immune responses against SARS-CoV-2 in over 80's

Health-related quality of life of COVID-19 patients with long-COVID: Study

Mandatory vaccines for health care workers might upend nurses’ training

COVID-19 may trigger hyperglycemia by disrupting key metabolic signals to cause severe disease

CDC awards $15.88 million to Wayne State University to study viral infection surveillance

EKF Diagnostics appoints Luke Daum as Chief Scientific Officer

Early-stage interaction of monocytes with SARS-CoV-2-infected epithelial cell decides COVID-19 severity

Study investigates long-COVID symptoms in people recovering from COVID-19 infection

The applications of nanomaterials against viral disease

Immunocompromised patients show decreased response to SARS-CoV-2 mRNA vaccines

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Influenza News and Research

Latest Influenza News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in